Literature DB >> 23546304

Spongiform encephalopathy in siblings with no evidence of protease-resistant prion protein or a mutation in the prion protein gene.

Daniela Varges1, Walter J Schulz-Schaeffer, Wiebke M Wemheuer, Insa Damman, Matthias Schmitz, Maria Cramm, Kai Kallenberg, Katayoon Shirneshan, Manar Elkenani, Susanne Markwort, Michael Faist, Jürgen Kohlhase, Otto Windl, Inga Zerr.   

Abstract

We discuss relevant aspects in two siblings with a neurodegenerative process of unclear aetiology who developed progressive dementia with global aphasia and hyperoral behaviour at the ages of 39 and 46 years and who died 6 and 5 years after disease onset. The cases were reported to the National Reference Center for TSE Surveillance in Göttingen, Germany. Detailed clinical examinations, CSF, blood samples, and copies of the important diagnostic tests (magnetic resonance imaging, electroencephalogram, laboratory tests) were obtained. Further neuropathological and genetic analyses were performed. Cerebral magnetic resonance imaging of both siblings showed prominent changes in signal intensity, especially in the left medial temporal cortex, but also the hippocampal formation. Neuropathological examination revealed spongiform changes, neuronal loss, and astrocytic gliosis, which are typical in Creutzfeldt-Jakob disease. However, no prion protein deposits were detectable by immunohistochemical analysis, Western blot, or PET blot, though abundant tau protein deposits were observed. A mutation in the coding region of the prion protein genes of both siblings was excluded. A detailed search of the literature revealed no other cases with a similar clinical and neuropathological appearance. While the disease aetiology remains unclear, the findings point to a neurodegenerative process and most likely a genetic disease.

Entities:  

Mesh:

Year:  2013        PMID: 23546304     DOI: 10.1007/s00415-013-6897-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  26 in total

1.  First report of Creutzfeldt-Jakob disease occurring in 2 siblings unexplained by PRNP mutation.

Authors:  Thomas E F Webb; Suvankar Pal; Durrenajaf Siddique; Dominic C Heaney; Jacqueline M Linehan; Jonathan D F Wadsworth; Susan Joiner; Jon Beck; Stephen J Wroe; Valerie Stevenson; Sebastian Brandner; Simon Mead; John Collinge
Journal:  J Neuropathol Exp Neurol       Date:  2008-09       Impact factor: 3.685

2.  Human transmissible spongiform encephalopathies.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1998-11-20

3.  Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.

Authors:  P Parchi; R Castellani; S Capellari; B Ghetti; K Young; S G Chen; M Farlow; D W Dickson; A A Sima; J Q Trojanowski; R B Petersen; P Gambetti
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

4.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Genetic prion disease: the EUROCJD experience.

Authors:  Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

6.  Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada.

Authors:  A Ladogana; M Puopolo; E A Croes; H Budka; C Jarius; S Collins; G M Klug; T Sutcliffe; A Giulivi; A Alperovitch; N Delasnerie-Laupretre; J-P Brandel; S Poser; H Kretzschmar; I Rietveld; E Mitrova; J de Pedro Cuesta; P Martinez-Martin; M Glatzel; A Aguzzi; R Knight; H Ward; M Pocchiari; C M van Duijn; R G Will; I Zerr
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910

7.  High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands.

Authors:  P Rizzu; J C Van Swieten; M Joosse; M Hasegawa; M Stevens; A Tibben; M F Niermeijer; M Hillebrand; R Ravid; B A Oostra; M Goedert; C M van Duijn; P Heutink
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

8.  Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease.

Authors:  B Meissner; K Kallenberg; P Sanchez-Juan; A Krasnianski; U Heinemann; D Varges; M Knauth; I Zerr
Journal:  AJNR Am J Neuroradiol       Date:  2008-07-03       Impact factor: 3.825

9.  Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies.

Authors:  M Pocchiari; M Puopolo; E A Croes; H Budka; E Gelpi; S Collins; V Lewis; T Sutcliffe; A Guilivi; N Delasnerie-Laupretre; J-P Brandel; A Alperovitch; I Zerr; S Poser; H A Kretzschmar; A Ladogana; I Rietvald; E Mitrova; P Martinez-Martin; J de Pedro-Cuesta; M Glatzel; A Aguzzi; S Cooper; J Mackenzie; C M van Duijn; R G Will
Journal:  Brain       Date:  2004-09-10       Impact factor: 13.501

10.  Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease.

Authors:  Lynne I McGuire; Alexander H Peden; Christina D Orrú; Jason M Wilham; Nigel E Appleford; Gary Mallinson; Mary Andrews; Mark W Head; Byron Caughey; Robert G Will; Richard S G Knight; Alison J E Green
Journal:  Ann Neurol       Date:  2012-08       Impact factor: 10.422

View more
  2 in total

Review 1.  Neurological update: dementia.

Authors:  A J Larner
Journal:  J Neurol       Date:  2014-02-06       Impact factor: 4.849

2.  PrP(ST), a soluble, protease resistant and truncated PrP form features in the pathogenesis of a genetic prion disease.

Authors:  Yael Friedman-Levi; Michal Mizrahi; Kati Frid; Orli Binyamin; Ruth Gabizon
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.